RBC Capital Downgrades Connectics (CNCT) to Market Perform
More News related to CNCT
- 180 Connect (CNCT) Higher Following DIRECTV Buyout
- StreetInsider.com Pre-Open Movers 12/21
- StreetInsider.com After-Hours Movers 12/20
- Standard & Poor’s Changes: SE, MOV
- RBC Capital Downgrades Connectics (CNCT) to Market Perform
More News related to Downgrades
- Hydrogenics Resumes Trading Under NASDAQ Symbol "HYGS"
- Varian Medical (VAR) to Highlight its New Range of Detectors at Annual RSNA Meeting in Chicago
- Manulife (MFC) Confirms No Exposure to Dubai World
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Seiko Epson to Transfer Sales Function of Small and Medium-Sized TFT LCD Business to Sony (SNE)
RBC Capital downgrades Connectics (Nasdaq: CNCT) from Outperform to Market Perform.
Connetics Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market.
Related Categories
DowngradesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
